With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Phase II Trial of Poly-ICLC in Pediatric Low Grade Gliomas||University of California, San Diego / Donald Durden, MD, PhD||Springboard Grants||2013||California|
|Assess the activity of ABT-737 as a single agent against neuroblastoma cell lines grown in cell culture||Children's Hospital Los Angeles / Theresa Harned, MD||Young Investigator Grants||2006||California|
|Genomic Alterations in Medulloblastoma||Children's Hospital Los Angeles / Shahab Asgharzadeh, MD||Young Investigator Grants||2008||California|
|Synergistic Activity of Anti-GD2 Antibody and CD47-Blockade for Immunotherapy of Neuroblastoma and Osteosarcoma||The Board of Trustees of the Leland Stanford Junior University / Robbie Majzner, MD||'A' Award Grants||2019||California|
|Understanding the Role of Translational Control in Humanized Mouse Models for Medulloblastoma||University of California San Francisco / Ozlem Aksoy, PhD||Young Investigator Grants||2015||California|
|Symptom Burden, Health-Related Quality of Life and Health Care Utilization Among Children Undergoing Hematopoietic Stem Cell Transplantation: Impact of Parent Sleep, Fatigue and Psychological Distress||Children's Hospital Los Angeles / Jessica Ward, PhD||Nurse Researcher Fellowship Grant||2017||California|
|Alternative Splicing Driven by MYCN Activates RAS-MAPK in Neuroblastoma||University of California San Francisco / William Weiss, MD/PhD||Innovation Grants||2018||California|
|Oncogenic Hedgehog Pathway Activation by a Putative Rho GTPase-Activating Protein||Lucile Packard Children's Hospital at Stanford University School of Medicine / Jun Ni, PhD||Young Investigator Grants||2013||California|
|Targeting the ALT Pathway to Induce Synthetic Lethality and Treat Poor Outcome Pediatric Tumors||University of California, Davis / Wolf-Dietrich Heyer, PhD||Innovation Grants||2018||California|
|Develop a Therapeutic Vaccine Approach by Removing Viral Immune Evasion||University of California, Los Angeles / Ren Sun, PhD||Springboard Grants||2013||California|